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Summary 
The class II major histocompatibility complex genes all contain in their proximal promoters 
three cis-elements called S, X, and Y  that are conserved in both sequence and position,  and a 
fourth element, J, conserved in sequence but not in position. J, X, and Y and, to some extent, 
S, have been shown to be functionally important in regulation of expression of these genes. In 
the present study, a protein factor that binds cooperatively to the S plusJ elements of the promoter 
of the class II major histocompatibility complex gene DPA has been detected. Moreover, functional 
cooperativity between S and J in activation of the enhancerless -40 interferon-3 (-40 IFN-3) 
promoter has been demonstrated. Finally, the latter assay appears to subdivide complementation 
group A of class II negative human B cell lines that includes both mutants generated in vitro 
and cells from patients with the bare lymphocyte syndrome (type II). In three of these cell lines, 
the enhancerless -40 IFN-3 promoter containing the S plus J elements was functionally active, 
while in the others it was inactive. 
T 
he human class II MHC genes play an essential role in 
class II MHC-restricted presentation of peptide antigens 
for generation of an antibody response and in some cases also 
for a class II MHC-restricted CTL response (Thl cells) (1, 2). 
The regulation of class II protein cell surface expression is, 
therefore, an important first step in control of the initiation, 
character, and magnitude of an immune response. Inappro- 
priate expression may lead to autoimmune disease, or alter- 
natively, decreased expression of class II may enable evasion 
of recognition by T  cells. 
Moreover, a disorder of class II MHC gene regulation, the 
class II bare lymphocyte syndrome (BLS), 1 has been described 
(3-5).  The disease is manifested by agammaglobulinemia, 
malabsorption, and T cell unresponsiveness to antigens and 
mitogens. The cell lines established from BLS patient's PBL 
as well as several similar mutant B cell lines generated in vitro 
do not express any of the three subtypes of class II antigens 
(HLA-DR, -DQ, and -DP) (6, 7), with the exception of one 
unusual cell line that expresses only DQ (8). Southern blots 
have shown that all of the ot and/3 chain genes encoding 
1 Abbreviations used in this  paper: BLS, bare lymphocyte  syndrome;  CAT, 
chloramphenicol  acetyltransferase;  EMSA, electrophoretic  mobility  shift 
assay; hGH, human  growth  hormone;  pRSV, plasmid  Ikous sarcoma  virus; 
TAF, trans-acting transcription factor. 
these glycoproteins in a subregion of the human MHC on 
chromosome 6  are intact  in  these mutant  cell lines,  but 
Northern blots revealed that they have little or no class II 
mRNA. Somatic cell hybridization of each of these mutant 
cell lines with normal human or mouse B cell lines results 
in stable  hybrid cell lines which express the class II genes 
of the mutant cells (9-12). The defect, which behaves as an 
autosomal recessive trait, does not segregate with the MHC, 
suggesting that the syndrome is due to a defective or inactive 
trans-acting  transcription factor (TAF) (3,  13). Analysis of 
transient heterokaryons produced by fusion of all available 
mutant cell lines in vitro showed that they fall into at least 
three and probably four different complementation groups 
(14-17).  The class II MHC-negative mutant cell lines pro- 
vide an important system for identifying genes controlling 
class II MHC gene expression. Recently, a gene for a factor, 
CIITA, defective in RJ2.2.5 cells, a member of complemen- 
tation group A, was isolated by complementation cloning 
(18, 19). Transfection of this gene restored expression of all 
class II MHC isotypes in RJ2.2.5 cells. The factor, however, 
is not a DNA binding protein but may represent a coacti- 
vator of the X  and Y  boxes. 
A  set of conserved upstream sequence elements, termed 
S, X, and Y boxes, are found in the proximal promoters of 
all class II MHC genes. Functional roles for the X  and Y 
boxes in the regulation of class II gene expression has been 
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letion as well as site-directed and linker scanning mutagen- 
esis, and a number of factors that bind to these dements have 
been described (6,  7).  The function of the S dement (20) 
is not well understood although it is thought to participate 
in MHC class II gene regulation in a position-dependent 
manner (21-23). However, constructs containing the X and 
Y elements alone are inactive in B ceils and are not restored 
by the S dement itself (24).  Moreover, a fourth element, J, 
that does restore activity of these constructs has been described 
that is conserved in sequence  but not in position (24-26). 
In the present study both nuclear protein binding to and 
functional enhancer activities of the S and J dements of the 
HLA-DPA gene have been examined. Cooperative interac- 
tion between the S and the J elements of DPA is an impor- 
tant feature in both assays. Moreover, these studies appear 
to subdivide complementation group A of dass II-negative 
B cell lines. 
Materials  and Methods 
Reagents.  rIFN-'y (referred to throughout as IFN-7) was gener- 
ously provided by Biogen (Cambridge, MA). The human growth 
hormone (hGH) assay  kit (Nichols Institute Diagnostics, San Juan 
Capistrano, CA) and oligonucleotides (Oligos etc. Inc., Guilford, 
CT) were purchased. 
Cell Lines.  Raji (ATCC CCL86) is a Burkitt's lymphoma B 
cell line that expresses high levels of all three class II isotypes of 
proteins. HeLa (CCL2; American Type Culture Collection, Rock- 
ville, MD) is a cervical carcinoma cell line. While resting HeLa 
cells do not express class II determinants, HLA-DR and -DP, but 
not -DOo can be induced by IFN-'y (27). HPB-ALL  is a human 
T cell tumor line that does not express class II proteins. 
The Epstein-Barr virus-transformed B cell lines derived from 
class II-deficient patients have  been described  elsewhere (16); BCH, 
BLS-2, Ramia, Nacera, and TF, and the laboratory-generated mu- 
tants, RJ2.2.5, RM-2, RM-3, Clone 13, and 6.1.6, were used and 
grown as previously. All except Clone 13 lack DR, DOo and DR 
Clone 13, however, express  DQ selectively,  but not DR or DP (8). 
Plasmids andAssays.  The control plasmid  pRSVCAT (Rous sar- 
coma virus long-terminal repeat linked to the chloramphenicol 
acetyltransferase [CAT] gene), pTK CAT (TK promoter nucleo- 
tides - 105 to + 11 in pUC18 vector), and p40 IFN-3 CAT (IFN-3 
promoter nucleotides -40 to +20 in pSP73 vector) have been de- 
scribed (28-30) and were the kind gift of T. Maniatis (Harvard 
University, Cambridge, MA). Oligonucleotides corresponding to 
the DPA and DQB sequences from positions -124 to  -118 (S of 
DPA, 7 bp), -107 to -98 (J of  DPA, 10 bp), -124 to -98 (S and 
J of DPA, 27 bp), -146 to -131 (J and S [or W] of  DQB, 16 bp), 
were synthesized. Fragments corresponding to the minimum pro- 
moter region from positions -148 to -11 (DPA) or -160 to +39 
(DQB) were purified after digestion with BamHI of the pDPA/ 
148hGH plasmid and with HindIII of the pDQB/160CAT plasmid, 
respectively  (24). These oligonucleotides  and fragments were cloned 
into the BamHI site of the pUC18-CAT vector upstream of the 
TK promoter or into the BamHI site of the pSP73-CAT vector 
upstream of  the -40 IFN-3 promoter. Mutations in the S element, 
the J element, and the interspace region in the constructs containing 
the fragment  -148 to  -11 of the DPA promoter, and the S+J 
region of the DPA promoter in the -40 IFN-3 CAT plasmid were 
made by PCR using the method of Giebel and Spritz (31). The 
5' and the 3' primers corresponding to the sequences in the vector 
were 5'-  AATACGACTCACTATAGGG-3'  and 5'-TTTTCTCCA- 
TTTTAGCTTCCTTAGCTCCTG-3', respectively. The primers 
used for making mutations in the S element, the interspace region, 
and the J dement in the  -148 to  -11 DPA promoter fragment 
containing  plasmid were  5'-CATCTCTTCCCCAGCATGCA- 
CCAGCGTCCTCTTTAC-3' 5'-CCCCAGCACCTTCCAGATC- 
TCTCTTTACCCAGCAAC-3' and 5'-GCGTCCTCTTTTCCC- 
AGCAACAG-3', respectively. The  primers used for  making 
mutations in the S element, the interspace region, and the J de- 
ment in the DPA S  +J region containing plasmid  were 5'-TCTAGA- 
GGATCCAGCATGCACCAGCGTCCTCTTTAC  -3 ',  5'-ATC- 
CAGCACCT TCCAGATCTCTCTTTACC CAGGGAT-3  '  and 
5'-AGCGTCCTCTTTTCCCAGGGATCCC-3', respectively. The 
bold letters indicate the mutated bases. 
Transfection of HeLa ceU lines was performed by the calcium 
phosphate method as described (25, 32). Raji cells  were transfected 
by electroporation in PBS plus 10 mM Hepes, pH 7.4 (24). Trans- 
fections also included 2 ~g ofpRSVhGH (33) as internal controls 
to normalize  for small  differences  in transfection  effidendes (<15%). 
Approximately 48 h after transfection, the supematant and cells 
were harvested  by centrifugation and assayed  for hGH activity and 
CAT activity essentially  as described (33). For quantitative analysis 
a blot  analyzer (Betascope 603; Betagen, Waltham,  MA) was 
used (34). 
Nuclear Extracts and Electrophoretic Mobility Shift Assay (EMSA). 
Nuclear extracts were prepared (35), from Raji, or confluent cul- 
tures of IFN-'y-treated and untreated HeLa cells using "o10  s cells. 
Protein concentration was measured using the Bradford protein 
assay (Bio-Rad Laboratories, Hercules, CA). The sequence of oli- 
gonucleotides used in the gel shift (only sense strand shown) ex- 
periments  are  5'-GATCCCGCACCTTG,  S element  of DPA; 
5'-GATCCCTTTACCCAGG-3',  J  element  of DPA; 5'-GAT- 
CCGCACCTTCCAGCGTCCT~CCCAGG-3', S andJ ele- 
ments of DPA; and 5'-GATCCC'IGGAT'I~AGAACCTTG-3' 
J and S elements of DQB. The sequences of the mutant oligonu- 
cleotides used in gel shift are as follows: 5'-GATCCTACAAGG 
CCAGCGTCCTCTTTACCCAGG-3',  S +J of DPA with muta- 
tions in S; 5'-GATCCGCACCTTCCAGCGTCCTAGGGCAA. 
ACTG-3', S+J of  DPA with mutations inJ. The S dement is itali- 
cized and underlined; the J dement is in bold type and underlined. 
Each oligonucleotide has 5' and 3' BamHI linkers for cloning. The 
BamHI fragment of  pDPA/148 (positions -148 to -11 of the DPA 
promoter), and EcoRI/HindIII fragment (51 bp) of pUC18 poly- 
linker were also used. Gel shift assays  were performed as described 
(36) with slight modification  (24) using end-hbeled  DNA fragments. 
Results 
Protein Complexes Detected by EMSA  Using Various  J  Ele- 
ment Probes.  First, nuclear proteins were detected by EMSA 
with theJ element probe of the DPA promoter (10 bp) alone 
using nudear extracts of four different types of cells: Raji, 
which expresses class II MHC protein constitutively, HeLa, 
which is class II MHC protein negative, HeLa treated with 
IFN-'y to induce class II MHC protein expression, and HPB- 
ALL, a class II-negative human T  cell line as a control A 
single specific protein or protein complex that bound only 
weakly to theJ element probe alone was detected in the class 
II-positive cell lines, Raji (Fig.  1 A, lane 2) and IFN-3, in- 
duced HeLa (Fig. 1 A, lane 4), but not in the two dass II-nega- 
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promoter. TheJ dement (10 bp) synthetic probe was used in EMSA with 
nuclear extracts from four different type of cells; Raji (B cell line), unin- 
duced and IFN-3,-induced HeLa (cervical  carcinoma  cell line), and HPB- 
ALL (T cdl line). The arrow indicates  the specific  retarded  complex.  Faster 
migrating nonspecific  bands were observed,  i.e., competition with speofic 
oligonudeotides did not lead to their disappearance. A 20-M excess of 
each specific  unlabeled competitor oligonudeotide was used to compete 
for binding of the specific  labeled oligonudeotide. (B) Proteins that bind 
to the S plus J elements of the DPA promoter and the J plus S dements 
of the DQB promoter. The S plus J dements of DPA (27 hp) or the J 
plus S elements of DQB (16 bp) synthetic probes were used in EMSA 
with nuclear  extracts  from Raji  cells. The arrow indicates  the specific  retarded 
complex. A 20-M excess  of  each specific  unlabeled  competitor oligonude- 
otide was used to compete for binding of specific  labeled oligonudeotide. 
Note that in competition experiments with J phs S of DQB, the separate 
J and S probes were not used because these elements overlap  in the DQB 
promoter. (C) Competition with mutant oligonucleotides for the pro- 
tein-DNA complex formed with DPA S+J element. The probe used is 
a synthetic DPA S+J element 27 bp long. Nuclear extracts were made 
from Raji calls. The specific  complex is indicated. Lanes I and 2 are the 
free  probe and the probe with nuclear  extract. Lanes  3-6, 7-10, and 11-15 
show results of competition experiments with increasing amounts (20-, 
50-, 100-, and 200-fold) of cold wild-type S+J, S+J with mutations in 
S, and S+J with mutations in J elements, respectively. 
tive cell lines (Fig.  1 A,  lanes 3  and 5).  This complex was 
competed out by unlabeled synthetic J  element probe (Fig. 
1 A,  lanes  7 and 9) or by a synthetic probe that contained 
the overlapping J  and S elements of DQB  (Fig.  1 A,  lanes 
12 and 14). Several nonspecific complexes were also observed 
that were not competed out by either of these probes.  No 
specific protein bands  could be observed using  a  synthetic 
S element of DPA probe (7 bp) (data not shown). These results 
strongly suggest that the J  elements of DPA and DQB bind 
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a  factor(s)  in  common.  Although  the J  element  of DPA 
overlaps the  5' end of the X  box (Xt box),  that  of DQB 
does not (24-26).  Nevertheless, the possibility that the ob- 
served specific complex includes proteins that bind to X1 is 
not excluded because some complexes may bind  to  several 
different elements and be linked by a common protein (see, 
for example,  reference 37). 
When synthetic probes encompassing both the S and the 
J  elements of DPA (27 bp) or the J  and S elements of DQB (16 bp) (see Materials  and Methods, and reference 24) were 
used as probes, a single band was again detected but had much 
greater intensity (Fig. 1 B). Strikingly,  this band could not 
be competed out by synthetic J or S elements  alone (Fig.  1 
B, 20-fold  molar excess, lanes 4,  5,  10,  and  11), but only 
by the synthetic oligonucleotide containing both elements, 
derived either from DPA or from DQB (Fig.  1 B, lanes 3 
and 9). These data suggest that a cooperative interaction  be- 
tween the J and S elements occurs in the binding of this pro- 
tein  or protein complex, even though no binding to the S 
element  alone could be detected.  Moreover,  the binding to 
the probe containing both elements  (Fig. 1 B) was substan- 
tially stronger than that observed with the J element alone 
(Fig. 1 A). The results suggest that S andJ elements of DPA 
and DQB bind a common factor and is compatible with an 
earlier report that the J element  of DQB can function as a 
positive regulatory element for cooperation with the X and 
Y boxes of DPA (24). When the DPA S+J element was used 
as a probe and competition was carried out with unlabeled 
wild-type S+J element  (Fig.  1 C, lanes 3-6),  or with S+J 
element  with mutations in the S element  (lanes 7-I0),  or 
in the J element (see Materials  and Methods) the wild-type 
S +J element competed very effectively. However, mutations 
in the S element alone reduced the ability of the oligonucleo- 
tide to compete with the wild-type probe for complex for- 
mation, while mutations in theJ element abolished its ability 
to compete, thereby providing support for the suggestion that 
cooperativity exists between S andJ element in the DPA pro- 
moter in the binding  of nuclear  proteins. 
Enhancer  A_ctivity  of  the S andJ Elements in CAT Assays.  The 
role of the S and J elements  as functional enhancers was ex- 
amined  using  heterologous  promoters.  Two  enhancerless 
promoters, the minimal TK promoter (which has three c/s- 
elements, Spl, CCAAT,  and a TATA box) (29) and the  -40 
IFN-B promoter (which has only one c/s-acting element,  the 
TATA box) (30) have been used to examine the enhancer ac- 
tivity of  the J and S elements alone or in combination. Using 
TK promoter,  substantial  activity of the enhancerless  pro- 
moter alone was observed in the class II protein-positive B 
cell line, Raji (Fig. 2; compare lane 2, no insert,  with lane 
1, the positive control pRSVCAT). An increase in activity 
was observed with the entire DPA promoter (-148 to  -11 
bp) in either orientation (Fig. 2, lanes 10 and  11). A lesser 
degree  of enhancement  was observed  with the synthetic J 
element alone (Fig.  2, lanes 3  and  4) and with the S plus 
J elements  (Fig. 2,  lanes  7 and  8).  A  multimerized S plus 
J element  gave maximal enhancement  (Fig. 2, lane 5).  No 
enhancement  was observed with the S element  alone, either 
as a single copy or multimerized (Fig. 2, lanes 5 and 6). Much 
weaker enhancement was observed with the DQB promoter 
in either  orientation (Fig. 2, lanes 15 and 16) or with its J 
plus S element (Fig.  2,  lanes 12,  13,  and  14). 
The enhancerless  -40 IFN-fl promoter yielded striking 
data. This promoter was virtually inactive in Raji cells (com- 
pare lanes  1 and 2 in Fig.  3 A) and  similarly,  the J  and  S 
elements  alone  of DPA were inactive  either in single copy 
or multimerized form (Fig. 3 A, lanes 3-6).  However, the 
Figure 2.  Plasmids  containing DPA and DQB synthetic  oligonucleo- 
tides linked to the TK promoter and their CAT activities  in Raji B cells. 
10 #g of CAT reporter plasmid and 2/Lg of pRSVhGH normalization 
plasmid were transfected into Raji cells by electroporation as described 
in Materials and Methods. The SEM for the normalization plasmid was 
<15% in this and all following  experiments. Crude extracts were  assayed 
for CAT activity  by TIC. This experiment was repeated three times in 
Raji cells with similar results each time. An autoradiogram of a typical 
assay is shown. 
synthetic probe containing  the S plus J  elements  in either 
orientation (Fig. 3 A,  lanes 7 and  8) and in a single copy 
as well as multimerized (Fig. 3 A, lanes 7, 9, and 10) were 
highly active relative to the intact promoter DPA (Fig. 3 A, 
lanes 11 and 12). These data confirm the in vitro EMSA results 
(Fig. 1 B) in showing a cooperative interaction  between the 
S and J elements using in vivo CAT activity. The DQB pro- 
moter or its J plus S elements  were also active, but less so 
(Fig.  3 A,  lanes  13-I7). 
Similar results with the  -40 IFN-B promoter were also 
obtained using HeLa cells (Fig. 3 B). No activity of any con- 
struct was demonstrable in uninduced HeLa cells. In IFN-3'- 
induced HeLa cells, the combination of S plus J elements of 
DPA was strikingly active as compared to either element alone 
(Fig.  3 B, lanes 3-6),  and  was active in either  orientation 
and as a monomer or multimer (Fig. 3 B, lanes 7-I0). The 
J plus S elements of  DQB had minimal activity in this system 
corresponding to the fact that DQA and DQB genes cannot 
be induced  by treatment with IFN-'y in HeLa cells (Fig. 3 
B, lanes I3-17). 
The effect of mutations in the S element,  in the interspace 
region and in the J element of the  -40 IFN-fl CAT plasmid 
containing  either the -  148 to - 11 DPA promoter fragment 
or the S+J region of the DPA promoter alone  are shown 
in Fig. 3 C. Mutations in either  the S element  or the J ele- 
ment alone significantly reduced the activity as they did in 
the gel shift assay (Fig. 1 C). The effect of mutation in the 
J element  was again greater  than the effect of mutation in 
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tides linked to the -40 IFN-fl promoter and their CAT activities in Raji, 
and uninduced and IFN-~/-induced HeLa cells. (,4) In Raji cells. 10/~g 
of CAT reporter plasmid and 2/~g of pRSVhGH normalization plasmid 
were transfected into Raji cells  by electroporation as described  in Materials 
and Methods. Crude extracts were assayed for CAT activity by thin layer 
chromatography. This experiment was repeated three times in Raft cells 
with similar  results each time. An autoradiogram  of a typical  assay  is shown. 
(B) In HeLa cells without or with IFN-y treatment. 10/~g of CAT reporter 
plasmid and 2/~g of pRSVhGH normalization plasmid were transfected 
into HeLa cells  by the calcium phosphate method as described in Materials 
and Methods. 2 d after treating the transfectants with IFN-"/(500 U/ml), 
crude extracts were assayed  for CAT activity by TLC. These experiments 
were repeated three times in HeLa cells with similar results each time. 
An autoradiogram of a typical assay  is shown. (C) 10/~g of CAT reporter 
plasmid was transfected into Raji cells by electroporation as described in 
Materials and Methods. Crude extracts were assayed for CAT activity by 
thin layer chromatography and subsequent quantitation  on a Betascope. 
CAT activities are reported as relative CAT activity where the activity 
of the wild-type insert is considered as 100%. Mutations in the S element, 
the interspace region, and the J element in the  - 148 to  - 11 DPA pro- 
moter construct brought down the CAT activity to 19, 87, and 7% of the wild-type, respectively.  Mutations in the S element, the interspace region, 
and the J element in the context of DPA S  +J brought down the activity to 19, 80, and 6% of the wild type, respectively.  The CAT activities reported 
are the average of three independent transfections. The actual percentage of conversion for the wild-type insert is shown in parentheses. Each number 
represents the arithmetic mean of three independent transfections. The SEM was <20%. 
the S element.  Mutations  in the interspace region had little 
or  no  effect. 
Transfection of  the -40 IFN-fl Promoter CAT Constructs into 
Normal and Class II Protein-negative Mutant BLS Patient Cell 
Lines.  Examination of B cell lines belonging to various BLS 
complementation groups in comparison to Raji cells as well 
as to HeLa cells (without  or with induction by IFN-3,) was 
next carried out  (Table 1 and Fig.  4) to determine if any of 
the transactivating defects in these cell lines is linked to the 
S and J elements. For these experiments, the intact DPA pro- 
moter (pDPA/148) which could activate the  -40 IFN-fl pro- 
moter in Raji cells and IFN-3, induced HeLa (Fig.  3 A) was 
used as a control. As expected, this promoter had nearly basal 
activity in all of the class II-negative cell lines.  Similarly to 
Raji cells, in cells of complementation groups B, C, D,  and 
in  three  of the  six cells  in  group  A,  the  S plus J  elements 
together activated the  -40 IFN-fl promoter, but no activity 
was  observed with  either  element  alone  (Table  2  and  Fig. 
4). By contrast, in the other three cell lines in complementa- 
tion group A, RM-2, Clone13,  and BCH, no activity could 
be detected. Clone 13 and BCH had already been recognized 
to differ in some respects from other members of complemen- 
tation group A (16, 38), and these experiments appear to sub- 
divide  this  complementation  group  further. 
Discussion 
The control  of gene  regulation  requires  protein-protein 
and  protein-DNA  interaction.  Many  transcription  factors 
mediate  the regulation  of DNA  transcription  by virtue  of 
their ability to specifically interact with particular DNA  se- 
quences  and  proteins  of the  basal  transcription  apparatus 
(39-42).  These transcription factors contain at least two do- 
mains: the DNA binding region which positions the protein 
on the DNA  and  the  activating region  that  interacts  with 
the transcription  complexes (43).  These transcription  com- 
179  Sugawara  et al. Table  1.  Activities of -  40 IFN-~ CAT Reporter Plasmids in Different Mutants of Complementation Group A 
Relative  CAT activity of -40 IFN-fl promoter plasmids (%) 
Cell lines  pRSVCAT  -  J  S  S  +  J  pDPA/148 
Controls  %  %  %  %  %  % 
Raji  100 (45.4)  6.7  6.6  5.8  76  207 
HeLa (-IFN-3')  100 (38.3)  3.1  3.0  3.7  2.6  3.6 
(+ IFN-3')  100 (34.4)  7.8  4.8  5.1  38  135 
BLS phenotype 
Complementation group A 
(type II) 
BCH  100 (16.5)  0.5  0.4  0.4  1.5  1.0 
BLS-2  100 (12.9)  0.7  0.6  0.6  44  17 
RJ2.2.5  100 (66.1)  2.3  1.8  2.6  64  14 
RM-2  100 (56.0)  2.5  1.7  1.8  9.8  5.7 
RM-3  100 (52.1)  2.8  1.8  2.0  23  3.4 
Clone 13  100 (93.3)  1.3  1.0  1.1  4.4  7.1 
Complementation  group B 
(type III) 
Nacera  100 (36.2)  1.0  0.9  0.9  77  7.9 
Ramia  100 (49.8)  0.8  0.9  0.7  15  1.5 
Complementation  group C 
(type III) 
TF  100 (37.1)  0.5  0.8  0.6  16  1.0 
Complementation  group D 
(type  ?) 
6.1.6  100 (21.3)  5.3  5.0  5.0  58  21 
10/~g of CAT reporter plasmid and 2/zg of pILSVhGH normalization  plasmid were transfected into Raji, uninduced, and IFN-3,-induced HeLa 
and class II-negative  mutant and BLS patient cells by electrophoration  as described  in Materials and Methods. Crude extracts  were assayed for CAT 
activity  by TLC and subsequent quantitation on a Betascope. CAT activities are reported as relative  CAT activity  standardized to pILSVCAT  (100%) 
and are the average  results of three to four independent transfections. The actual percentage  of chloramphenicol  acetylated  using pRSVCAT in this 
series of transfections  is shown in parentheses in the first column. Each number represents the arithmetic mean of at least three independent transfec- 
tions. The SEM was <~20%. 
plexes include proteins (coactivators) that do not bind to DNA 
but mediate interactions between the DNA binding proteins. 
Regulation of transcription can be accomplished by modu- 
lating the quantities or activities of sequence-specific tran- 
scription factors. "Basal-level" transcription from R.NA poly- 
merase II promoters involves the formation of a multiprotein 
complex at the TATA box region, which contains RNA poly- 
merase II and a set of "general" transcription factors, such 
as TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH. "Acti- 
vated" transcription requires the binding of "regulatory" tran- 
scription factors to other DNA sequences in the promoter. 
These regulatory factors are thought to mediate activation 
by forming protein-protein interactions with the general tran- 
scription factors, sometimes through the protein-protein in- 
teractions of coactivators (44). Direct coordination between 
the regulatory gene specific or tissue specific and general tran- 
scription factors are not yet well established. However, four 
viral transactivating proteins, the adenovirus E1A (45, 46), 
the herpes virus VP16 (47), the Epstein-Barr virus Zta (48), 
and the cytomegalovirus IE2 (49), have been shown to con- 
tact directly the TATA box binding protein TFIID and, in 
the case of VP16,  the general factor TFIIB (50). 
The class II X  and Y  boxes are regulatory transcription 
elements necessary but not su~cient for maximal transcrip- 
tion of class II MHC genes. These c/s-elements  have been 
shown  to bind  the  transcription factors RF-X  (X1  box), 
hXBP-1 (X2 box), and NF-YA and YB (Y box) (6, 7). Other 
upstream elements such as the pyrimidine tract (Py), the S 
(also included in or called W, Z, or H), and the J element 
are required in addition to the X and Y boxes (6, 7, 24-26). 
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members  of  complementation  group  A. The control plasmids (pRSVCAT) 
and -40 IFN-3 plasmids used (Fig. 3 A) are shown  in the upper  left box. 
All of those inserts derived from the DPA gene had a single copy in the 
sense (+) orientation. Raji, the control cell line, is shown in the upper 
right box. Different subgroups of complementation group A (see Table 
2) are illustrated in the remaining boxes. 
The W  box was shown to be important  for optimal levels 
of B cell expression and essential for IFN-3' induction (51-53). 
Two protein complexes were preliminarily shown to interact 
with the W  box of the DRA gene, which includes overlap- 
ping J and S elements (54, 55). In a previous paper, the pos- 
sible role of the S and J elements in transcription  of human 
class II MHC genes was examined.  The S element is a con- 
served sequence element found 15 bp upstream of the X  and 
Y elements. X and Y function together as a specific enhancer 
of class II MHC gene expression (33).  S element  has been 
shown to be functionally important  for the DRA promoter 
(21, 22). Later,  as the results of 5' deletion and mutagenesis 
analysis,  a fourth element,  called the J  element,  was found 
in the DPA and DQB  genes (24).  A  similar  sequence ele- 
ment was located in the proximal promoters of each of the 
other human and murine class II MHC genes, but its pos- 
sible functional role in these other genes has not been exam- 
ined.  The J  element is located at different positions in the 
DPA,  DQB,  and other  class  II MHC genes and  thus  had 
not previously been detected by sequence alignments (24-26). 
Recently, two DNA binding proteins that bind to the J ele- 
ment,  but only in constructs which also contain the S ele- 
ment,  were identified.  One of these,  encoded by clone 18, 
has been studied in detail (56). This protein contains a novel 
conserved domain at its NH2 terminus,  a central  acidic  ac- 
tivation  region,  and  a COOH-terminal  DNA binding  re- 
gion containing 11 zinc fingers. Antisense constructs of each 
these new J element binding proteins dramatically inhibited 
IFN-3,-induced class II MHC gene expression in HeLa cells, 
but constitutive expression in established B cell lines was more 
difficult to inhibit (Sugawara, M. unpublished observations). 
The present  paper provides additional  evidence that  the 
S and J  elements function  together in the transcription  of 
class II MHC genes. First, in extracts of the Raji B cell line, 
a DNA binding complex was detected with the J  element 
probe alone (Fig.  1 A), but was much more prominent using 
probes containing both the S andJ elements (Fig. 1 B). Simi- 
larly, in competition experiments with oligonucleotides, com- 
petition could be observed only with competitors containing 
both S and J  (Fig.  1 B). Also, mutations  in  the DPA pro- 
moter S and J  elements individually,  but in the context of 
the S plus J  region, led to a significant loss in the ability of 
the mutant oligonucleotides to compete with the wild-type 
probe for the complex (Fig. 1 C). Hnally, using two enhanc- 
erless promoters, the TK promoter (Hg. 2) and the -40 IFN-B 
promoter (Fig.  3), the cooperativity of the S and J elements 
as enhancers, both in Raji cells which constitutively express 
class II MHC protein and in IFN-q,-induced HeLa cells, was 
dramatically illustrated.  Two different S and J  element  se- 
quences were used, that from DPA gene and that from the 
DQB gene,  in all of these experiments.  The two elements 
have different relative locations in  these two genes.  In the 
DPA gene, theJ element is located 10 bp downstream from 
the S element, and overlaps the X1 box. In the DQB gene, 
the J element is located immediately upstream  of the S ele- 
ment, which is overlapped by I bp. In the DPA gene in par- 
ticular, cooperativity of the two elements separated by 10 bp 
is unusual.  In any event, these results strongly suggest that 
the cooperativity of the S plus J  elements is a major tran- 
scriptional feature of regulation in class II antigen-positive 
Raft and IFN-?-treated  HeLa cells.  Further supportive evi- 
dence (Fig.  3 C') was provided by the  -40 IFN-3 promoter 
CAT assays which showed that mutations made in the S or 
the J element alone in the context of either the  -148 to  -11 
DPA  promoter  fragment  or  the  DPA  S+J  region  led  to 
significant  loss in CAT activity. Mutations made in the inter- 
space  region  had  a minor  influence. 
Finally, the function of the S plus J enhancer in class II-nega- 
tive human  B cell lines obtained either from patients with 
the BLS or produced by in vitro mutagenesis has been exam- 
ined (Fig.  4 and Table 2). These lines have previously been 
shown to fall into three and possibly four complementation 
groups. Members of each group have been examined. As ex- 
pected, the full proximal promoter of the DPA gene (- 148 
to  -11 bp containing  the S, J,  X,  and Y  elements)  when 
Table  2.  Phenotype  of Cells of Complementation Group A 
Cell lines  Activity of S  +  J*  DQ Expressiont 
Raji (control)  +  + 
RJ2.2.5,  RM-3, BLS-2  +  - 
Clone  13  -  + 
RM-2, BCH  -  - 
* Enhancer activity using the  -40 IFN-3 heterologous promoter. 
* Surface expression using the mAb Leu 10 for FACS  |  analysis. 
181  Sugawara  et al. cloned upstream of the  -40 IFN-/3  promoter was inactive 
in all of the class II-negative cell lines,  although high level 
activity of the same constructs was observed in Raji cells and 
in IFN-3,-induced HeLa cells. However, the S plusJ elements 
cloned upstream of the - 40 IFN-3 promoter were fully ac- 
tive in cells of complementation groups B, C, and D, indi- 
cating that the factor missing or defective  in these groups 
does not involve these elements. With cells representing com- 
plementation group A, a surprising anomaly was found. In 
three members of this group (RJ2.2.5, RM-3, and BLS-2), 
the S plus J elements were highly active, despite the lack of 
activity of the intact DPA promoter, as in groups B, C, and 
D. By contrast, in clone 13, tLM-2, and BCH, the activity 
was either very low or absent (57).  Thus, these cis-acting S 
and J elements must somehow be involved as a target(s) of 
transcription factor(s)  missing, defective,  or inactive in the 
RM-2, clone 13, and BCH mutant B cell lines.  Moreover, 
this assay subdivided members of complementation group 
A further. Previously, clone 13 had been distinguished from 
other members of group A by the fact that it expresses normal 
levels of DQ, although it is negative for DR and DP, while 
other members of the group, including both RM-2 and BCH, 
are negative for all three isotypes of class II protein. Thus, 
these experiments define three subgroups of complementa- 
tion group A (Table 2). In addition, BCH has previously been 
shown to differ from other members of the subgroup by in 
vivo footprinting (38).  A genetic defect has been identified 
in two members of group A cells, the in vitro mutant cell 
line RJ2.2.5 and the patient cell line BLS-2. This factor CIITA, 
which is IFN-3, inducible, and is not a DNA binding pro- 
tein, was shown to have a large deletion in RJ2.2.5 and to 
be missing an exon of 24 amino acids in the mRNA in BLS-2, 
as the consequence of a mutation in a splice donor site (18). 
The other members of this complementation group have not 
yet been examined, and thus one possibility would be that 
they differ in the precise defect in CIITA. Since these defects 
do not complement each other, (i.e., they all belong to com- 
ptementation group A),  they must carry mutations in the 
same gene.  One plausible  interpretation would be that this 
gene/protein, i.e., CIITA, interacts with multiple transcrip- 
tion factors (i.e., factors that bind to J, S, X, Y, TATA, and/or 
YY1 [58] boxes), and that the different defects involve muta- 
tions in different regions of CIITA specific for these different 
interactions.  For example, the defects in clone 13, RM-2, and 
BCH may involve a region required for interaction with S 
plus J  element binding proteins and would be reflected in 
the inability of the S/J elements in the heterologous promoter 
construct, the -40 IFN-3 promoter. (For an earlier  discus- 
sion of the anomaly of clone 13, see reference  16.) In any 
event, the manner in which the putative genetic defects might 
relate  to the failure of the S plus J  elements to function as 
enhancers in some cells of this complementation group and 
their normal function in other mutants remain to be examined. 
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